Whalen Erin J, Bates James N, Johnson Alan Kim, Lewis Stephen J
Department of Pharmacology, University of Iowa, Iowa City, IA, USA.
Br J Pharmacol. 2006 Apr;147(7):755-64. doi: 10.1038/sj.bjp.0706675.
The beta-adrenoceptor agonist, isoprenaline, elicits vasodilation and tachycardia in anesthetized rats via activation of propranolol-sensitive beta1- and beta2-adrenoceptors and also by propranolol-insensitive beta1- and beta3-adrenoceptors. The aim of this study was to determine whether the relative contribution of propranolol-sensitive and -insensitive beta-adrenoceptors to the changes in heart rate (HR) and vascular resistances elicited by isoprenaline is altered after blockade of nitric oxide (NO) synthase, in pentobarbital-anesthetized rats. The hemodynamic responses elicited by isoprenaline (0.1 and 0.5 microg kg(-1), i.v.) were determined before and after injection of saline or the NO synthase inhibitor, N(G)-nitro-L-arginine methylester (L-NAME, 50 micromol kg(-1), i.v.), and again after injection of the beta1- and beta2-adrenoceptor antagonist, propranolol (1 mg kg(-1), i.v.). The responses elicited by the above doses of isoprenaline were also determined before and during infusion of the alpha1-adrenoceptor agonist, phenylephrine (3 microg kg(-1) min(-1), i.v.), and again 15-20 min after injection of propranolol (1.0 mg kg(-1), i.v.). Both doses of isoprenaline elicited tachycardia and reductions in vascular resistances. Propranolol eliminated the responses elicited by the lower dose of isoprenaline and substantially diminished the responses elicited by the higher dose of the beta1-, beta2- and beta3-adrenoceptor agonist. The maximal vasodilator responses elicited by both doses of isoprenaline were not diminished whereas the maximal increases in HR were higher after injection of L-NAME. The ability of propranolol to diminish the hemodynamic actions of isoprenaline was substantially diminished in L-NAME-treated rats, whereas propranolol retained its potency in rats that received an equi-pressor infusion of the alpha1-adrenoceptor agonist, phenylephrine. The finding that the maximal vasodilator responses elicited by isoprenaline were not diminished by L-NAME suggests that the vasodilation elicited by this drug was due to direct activation of beta-adrenoceptors on vascular smooth muscle and that the full compliment of isoprenaline-sensitive receptors was not changed after inhibition of NO synthesis. However, these results suggest that the activities of propranolol-sensitive beta-adrenoceptors are downregulated, whereas propranolol-insensitive beta-adrenoceptors are upregulated upon the loss of exposure to endothelial nitrosyl factors.
β-肾上腺素能受体激动剂异丙肾上腺素,通过激活对普萘洛尔敏感的β1和β2肾上腺素能受体以及对普萘洛尔不敏感的β1和β3肾上腺素能受体,在麻醉大鼠中引起血管舒张和心动过速。本研究的目的是确定在戊巴比妥麻醉的大鼠中,一氧化氮(NO)合酶被阻断后,对普萘洛尔敏感和不敏感的β-肾上腺素能受体对异丙肾上腺素引起的心率(HR)和血管阻力变化的相对贡献是否改变。在静脉注射生理盐水或NO合酶抑制剂N(G)-硝基-L-精氨酸甲酯(L-NAME,50 μmol kg-1,静脉注射)之前和之后,以及在静脉注射β1和β2肾上腺素能受体拮抗剂普萘洛尔(1 mg kg-1,静脉注射)之后,测定异丙肾上腺素(0.1和0.5 μg kg-1,静脉注射)引起的血流动力学反应。在静脉输注α1肾上腺素能受体激动剂去氧肾上腺素(3 μg kg-1 min-1,静脉注射)之前和期间,以及在注射普萘洛尔(1.0 mg kg-1,静脉注射)后15 - 20分钟,也测定上述剂量异丙肾上腺素引起的反应。两种剂量的异丙肾上腺素均引起心动过速和血管阻力降低。普萘洛尔消除了较低剂量异丙肾上腺素引起的反应,并显著减弱了较高剂量β1、β2和β3肾上腺素能受体激动剂引起的反应。两种剂量的异丙肾上腺素引起的最大血管舒张反应没有减弱,而注射L-NAME后HR的最大增加更高。在L-NAME处理的大鼠中,普萘洛尔减弱异丙肾上腺素血流动力学作用的能力显著减弱,而在接受α1肾上腺素能受体激动剂去氧肾上腺素等压输注的大鼠中,普萘洛尔仍保持其效力。异丙肾上腺素引起的最大血管舒张反应未被L-NAME减弱,这一发现表明该药物引起的血管舒张是由于直接激活血管平滑肌上的β-肾上腺素能受体,并且在抑制NO合成后,异丙肾上腺素敏感受体的完整互补性没有改变。然而,这些结果表明,对普萘洛尔敏感的β-肾上腺素能受体的活性被下调,而对普萘洛尔不敏感的β-肾上腺素能受体在失去内皮亚硝酰因子暴露后被上调。